Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 221.6B | 218.5B | 209.2B | 215.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 63.0B | 8.6B | 63.2B | 66.6B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 81.8B | 98.9B | 90.1B | 91.8B |
Tax provision | 19.2B | 24.1B | 22.4B | 17.7B |
Net income | 62.8B | 75.1B | 67.8B | 74.4B |
Basic EPS | 20.2 | — | 21.8 | 23.9 |
Diluted EPS | 20.0 | — | 21.7 | 23.8 |
Basic average shares | 3.1B | — | 3.1B | 3.1B |
Diluted average shares | 3.1B | — | 3.1B | 3.1B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -357.7M | -339.7M | -366.2M | -344M |
Preferred stock dividends | — | — | — | — |